We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$880B
AUM Growth
+$147B
Cap. Flow
+$97B
Cap. Flow %
11.02%
Top 10 Hldgs %
14.5%
Holding
8,205
New
199
Increased
3,814
Reduced
2,948
Closed
311

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.71B
2
MSFT icon
Microsoft
MSFT
+$3.52B
3
AMZN icon
Amazon
AMZN
+$2.04B
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.87B
5
LLY icon
Eli Lilly
LLY
+$1.31B

Sector Composition

Rank Sector Weight
1 Technology 17.3%
2 Healthcare 12.11%
3 Financials 10.63%
4 Consumer Discretionary 8.09%
5 Industrials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAIL icon
5801
Cambria Tail Risk ETF
TAIL
$146M
$91.6K ﹤0.01%
5,988
+503
+9% +$7.89K
APRE icon
5802
Aprea Therapeutics
APRE
$7.98M
$91.3K ﹤0.01%
13,793
-1,808
-12% -$19.1K
PGAL
5803
DELISTED
Global X MSCI Portugal ETF
PGAL
$91K ﹤0.01%
9,040
+3,000
+50% +$28.9K
FRLN
5804
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$90.9K ﹤0.01%
12,760
+1,217
+11% +$11.6K
UROY
5805
Uranium Royalty Corp
UROY
$1.57B
$90.8K ﹤0.01%
38,294
-14,099
-27% -$34.3K
FCAP icon
5806
First Capital
FCAP
$213M
$90.7K ﹤0.01%
3,643
-45
-1% -$1.1K
VIRC icon
5807
Virco
VIRC
$93.6M
$90.7K ﹤0.01%
20,061
VIRX
5808
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$90.5K ﹤0.01%
61,981
-4,211
-6% -$12.3K
SQLV icon
5809
Royce Quant Small-Cap Quality Value ETF
SQLV
$40.9M
$90.4K ﹤0.01%
2,630
GLMD icon
5810
Galmed Pharmaceuticals
GLMD
$4.9M
$90.4K ﹤0.01%
1,004
-49
-5% -$3.21K
EGAN icon
5811
eGain
EGAN
$203M
$90.2K ﹤0.01%
9,985
-44,074
-82% -$363K
SMDD icon
5812
ProShares UltraPro Short MidCap400
SMDD
$1.92M
$90.2K ﹤0.01%
2,000
UJUL icon
5813
Innovator US Equity Ultra Buffer ETF July
UJUL
$297M
$90.1K ﹤0.01%
3,500
FNWB icon
5814
First Northwest Bancorp
FNWB
$105M
$89.7K ﹤0.01%
5,843
-4,875
-45% -$73.7K
LSBK icon
5815
Lake Shore Bancorp
LSBK
$134M
$89.7K ﹤0.01%
7,431
NJUL icon
5816
Innovator Growth-100 Power Buffer ETF July
NJUL
$260M
$89.6K ﹤0.01%
2,105
+280
+15% +$12.1K
OYST
5817
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$89.2K ﹤0.01%
7,986
-136,542
-94% -$1.32M
PHX
5818
DELISTED
PHX Minerals
PHX
$89.1K ﹤0.01%
22,896
-523,575
-96% -$1.96M
SSBI icon
5819
Summit State Bank
SSBI
$88.1M
$88.7K ﹤0.01%
5,616
-1
-0% -$16
CBD
5820
DELISTED
Companhia Brasileira de Distribuicao
CBD
$88.5K ﹤0.01%
28,555
-2,548,626
-99% -$9.26M
CEA
5821
DELISTED
China Eastern Airlines
CEA
$88K ﹤0.01%
4,361
-464
-10% -$8.65K
CTXR icon
5822
Citius Pharmaceuticals
CTXR
$18.6M
$88K ﹤0.01%
4,455
-1,485
-25% -$40.5K
BCEL
5823
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$87.9K ﹤0.01%
109,731
-71,821
-40% -$91.4K
LVO icon
5824
LiveOne
LVO
$60.4M
$87.6K ﹤0.01%
13,615
-30
-0.2% -$205
SVRN
5825
OceanPal Inc
SVRN
$11.8M
$87.5K ﹤0.01%
+8
New +$176K

Similar funds

Morgan Stanley's Q4 2022 Portfolio in Review

As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 199 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.

  • Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
  • Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
  • Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
  • Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
  • Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
  • Morgan Stanley opened 199 new positions and closed 311 in Q4 2022.
  • Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.